Company intelligence / Profile preview

CureLab Oncology

Boston, Massachusetts, United Statescurelaboncology.com ↗

Ownership: Private
Employees: ~14
Development stage: Other

Overview

CureLab Oncology has completed international Phase I/IIa clinical trials of its lead product, Elenagen™, demonstrating high safety and encouraging clinical benefits in patients with actively progressing tumors. The company has initiated or plans to initiate Phase II studies outside and within the United States. Elenagen can be used alone or in combination with standard chemotherapies, showing potential to enhance their efficacy. The company also explores applications beyond oncology, such as chronic pain management and inflammatory diseases.

Therapeutic areas: OncologyImmunologyNeurology
Modalities: DNA therapy (plasmid-based biologics)Immuno-oncology agents
Industry: Biotech

Drug pipeline

1 asset

Elenagen

Partnerships

Seeking partners for licensing/M&A and combination studies with targeted oncology agents; no specific partners named yet.

Beyond the preview

Go deeper on CureLab Oncology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CureLab Oncology.